A ketogenic diet reduced liver fat by 67 percent in adults with obesity and prediabetes over four months, outperforming Mediterranean and low-fat diets despite comparable weight loss across all study groups, according to research published in Cell Metabolism.
Ketogenic Diet Reduces Liver Fat and Reverses Prediabetes Without Raising Cholesterol
- Beyond the scale: Participants on a very low-carbohydrate diet lost liver fat faster and more thoroughly than those on other diets, even when total pounds lost were identical.
- Blood sugar impact: About half of the participants following the ketogenic plan no longer met diagnostic criteria for prediabetes after the intervention.
- Cholesterol surprise: Despite deriving nearly three-quarters of daily calories from fat, patients in the keto group did not experience increases in blood fat or cholesterol levels.
Clinical Comparison of Three Diets
An estimated 40 percent of American adults have obesity, a condition linked to type 2 diabetes and fatty liver disease. To determine whether specific nutritional compositions offer metabolic advantages beyond weight reduction, researchers at Washington University School of Medicine in St. Louis recruited 42 adults with obesity, prediabetes, and fatty liver disease.
Participants were randomly assigned to follow one of three eating plans: a ketogenic diet, a Mediterranean diet, or a plant-forward low-fat diet. The research team supplied all meals and arranged weekly dietitian consultations to ensure adherence. Calorie intake was adjusted individually so that participants in every group lost approximately 10 percent of their starting body weight over a period of four to five months.
| Dietary Approach | Carbohydrate % | Fat % | Liver Fat Reduction |
|---|---|---|---|
| Ketogenic | 4% | 73% | 67% |
| Mediterranean | 50% | 35% | 45% |
| Plant-Forward Low-Fat | 70% | 15% | 45% |
By the end of the intervention, every group showed meaningful reductions in body fat and improvements in insulin sensitivity. However, the ketogenic group achieved an average 67 percent reduction in liver fat, compared with a 45 percent reduction in both the Mediterranean and low-fat groups, ScienceDaily reported.
“We know weight loss can improve metabolic health in people who are obese,” Samuel Klein, the study’s corresponding author at Washington University School of Medicine in St. Louis, Missouri, told ScienceDaily. “Our data suggest that if you have high liver fat content and prediabetes, reducing carbohydrate intake can have important therapeutic effects on metabolism beyond just weight loss alone.”
Ketogenic Diet Boosts Glucagon, Lowers Insulin, and Avoids Blood Fat Increases
Blood samples collected over 24-hour periods revealed distinct physiological shifts in the ketogenic cohort. Participants following the keto plan showed the greatest increase in glucagon, a hormone that regulates energy supply and promotes the breakdown of stored liver fat. They also experienced the largest decrease in insulin levels.

“The most surprising finding was that participants in the ketogenic diet group didn’t experience an increase in blood fat or cholesterol levels despite consuming the most fat,” Max Petersen, the study’s first author at Washington University, told ScienceDaily.
The metabolic benefits extended directly to blood sugar regulation. Approximately 50 percent of participants assigned to the ketogenic diet no longer met the criteria for prediabetes after four to five months. By comparison, that milestone was reached by 29 percent of those on the Mediterranean diet and just 7 percent of those following the low-fat plan, tldrdailynews.com reported.
Researchers note that these findings arrive as GLP-1 receptor agonist medications transform obesity treatment by driving significant weight loss. “GLP-1-based medications have revolutionized the therapy of obesity. "We now have a very effective pharmacotherapy for achieving significant weight loss," Petersen told ScienceDaily. “Pero in addition, our study shows that the specific composition of the diet can give you added benefits.”
Washington University School of Medicine in St. Louis, founded in 1891, shares its campus with Barnes-Jewish Hospital and St. Louis Children’s Hospital.
The school rose to national prominence in the 1940s when faculty members received Nobel Prizes in 1944 and 1947; in the latter year, professor Gerty Cori became the first woman to win the Nobel Prize in Physiology or Medicine. Today, its physicians provide clinical care in more than 75 specialties across the BJC HealthCare system and the St. Louis region.
Next Steps in Metabolic Research
The clinical trial was supported by the National Institutes of Health and the Foundation for Barnes-Jewish Hospital. While the findings offer clear evidence that dietary composition influences metabolic health independently of weight loss, researchers emphasize that the trial was relatively small and lasted only four to five months.
Longer-term randomized controlled trials with larger participant cohorts will be necessary to determine whether these metabolic benefits persist over years and how different nutritional strategies compare across diverse patient populations.
References
- Cell Metabolism – Clinical trial on dietary composition, liver fat reduction, and prediabetes reversal.
- National Institutes of Health (NIH) – Research grant support and public health oversight.
- Washington University School of Medicine in St. Louis – Clinical investigation and faculty research reporting via ScienceDaily.